0
In a new study, scientists show that the two-dose vaccination regimen of mRNA vaccines provides 88 percent protection against non-variant virus, 86 percent against the Alpha variant, and 77 percent against the Beta variant.
In a new study, scientists show that the two-dose vaccination regimen of mRNA vaccines provides 88 percent protection against non-variant virus, 86 percent against the Alpha variant, and 77 percent against the Beta variant.